BACKGROUND: Goal-directed fluid therapy during major abdominal surgery may reduce postoperative morbidity. The Pleth Variability Index (PVI), derived from the pulse oximeter waveform, has been shown to be able to predict fluid responsiveness in a number of surgical circumstances. In the present study, we sought to determine whether PVI could predict fluid responsiveness in low-risk colorectal surgery patients who had fluid therapy guided by esophageal Doppler stroke volume measurements. METHODS: Twenty-five low-risk patients undergoing colorectal resection under general anesthesia were studied. Baseline values for esophageal Doppler stroke volume and PVI taken from finger and ear probes were compared with final values after (a) a 500-mL fluid bolus immediately after induction (steady state) and tracheal intubation before the start of the surgery, and (b) 250-mL boluses given in response to a decrease in stroke volume of 10% during surgery as measured by esophageal Doppler (dynamic). Patients were classified into responders and nonresponders based on a stroke volume increase of Ͼ10%. RESULTS: Baseline PVI at the finger was significantly higher in responders in both steady-state and intraoperative conditions. In steady state, PVI at both finger and earlobe had significant predictive ability of an increase in stroke volume: area under the curve for finger 0.96 (95% confidence interval [CI], 0.88 -1.00; P ϭ 0.011) and for earlobe 0.98 (95% CI, 0.93-1.00; P ϭ 0.008). In dynamic intraoperative conditions, PVI at the finger predicted increases in stroke volume, area under the curve 0.71 (95% CI, 0.57-0.85; P ϭ 0.006), but PVI at the earlobe had no predictive value. CONCLUSIONS: PVI measured at the finger may be able to predict fluid responsiveness during surgery in ventilated patients.
I mproving oxygen delivery by hemodynamic optimization with fluid and occasionally inotropic drugs has been shown to improve outcomes in the high-risk surgical patient 1 and reduce gastrointestinal morbidity. 2 Hemodynamic optimization has been facilitated with a variety of devices including the pulmonary artery catheter, arterial line, or the esophageal Doppler. Maximizing the stroke volume (SV) as measured by esophageal Doppler monitoring optimizes preload, and is a goal-directed fluid therapy technique that has been used in a variety of clinical situations in anesthesia, critical care, and emergency medicine. Goal-directed fluid therapy has been reported to be associated with improved gut perfusion 3 and decreased inflammatory response. 4 During major abdominal surgery, this may be reflected in faster recovery of gut function, 5 reduced length of hospital stay, 6 reduced complication rate, 5 and reduced incidence of critical care admission. 7 Preload responsiveness is an alternative approach to optimization of preload. Variation in the arterial pressure waveform during mechanical ventilation has been shown in some studies to be a reliable indicator of fluid responsiveness in patients with a stable heart rhythm. 8 Additionally, increases in SV variation (SVV), 9 systolic pressure variation, 10 and pulse pressure variation 11 have all been shown to be indicators of a likely responsiveness to fluid administration.
Recent advances in technology have allowed the continuous, automatic calculation of the variability of the pulse oximeter plethysmographic waveform amplitude during the respiratory cycle in the mechanically ventilated patient. The Pleth Variability Index (PVI) is the percentage variation in the plethysmograph and is calculated from the perfusion index (PI), which is described as the percentage of light absorbed as a result of arterial pulsation (AC) relative to total amount of light absorbed (DC).
PI ϭ (AC/DC) ϫ 100%. PVI is derived from changes in PI throughout the respiratory cycle such that.
PVI ϭ [(PImax Ϫ PImin)/PImax] ϫ 100% (manufacturer technical bulletin).
Changes in the amplitude of the pulse oximeter plethysmogram correlate closely with variation in pulse pressure, 3, 12, 13 and plethysmographic variability may be able to predict fluid responsiveness in intensive care or in a number of surgical circumstances with full hemodynamic monitoring. 14 -16 The aim of this study was to determine whether PVI, measured using finger and earlobe oximetry probes, predicts fluid responsiveness in lower-risk patients undergoing elective colorectal surgery, first during steady-state conditions before surgery, and second during dynamic intraoperative conditions.
METHODS
The York Hospital Research Ethics Committee granted approval for the study. Written informed patient consent was obtained from 25 ASA physical status I to II patients, aged 18 years or older, undergoing elective major colorectal surgery between February 2009 and January 2010. Patients were included if they had an oxygen uptake at anaerobic threshold Ͼ11 mL ⅐ kg Ϫ1 ⅐ min Ϫ1 on preoperative cardiopulmonary exercise testing, or if they did not fulfill the criteria for exercise testing (younger than 55 years with no comorbidities). Patients were excluded if the attending anesthesiologist thought they needed an arterial catheter or central venous catheter for intraoperative monitoring.
All patients received a standard anesthetic regimen. A thoracic epidural catheter was inserted under local anesthesia. A test dose of 3 mL of 0.5% bupivacaine was given through the epidural catheter and, after the steadystate test period and before surgery commenced, a standard epidural infusion of 0.1% bupivacaine and 4 g ⅐ mL Ϫ1 fentanyl was started at 6 mL ⅐ hϪ 1 to provide analgesia during and after surgery.
Anesthesia was induced using propofol 2 to 4 mg ⅐ kg Ϫ1 and fentanyl 1 to 2 g ⅐ kg Ϫ1 , and vecuronium 0.05 to 0.1 mg ⅐ kg Ϫ1 was used to enable oral endotracheal intubation. Anesthesia was maintained with oxygen-enriched air and isoflurane 1% to 2%. The patients' lungs were ventilated using a volume-controlled mode with a respiratory rate of 12 breaths ⅐ min Ϫ1 and a tidal volume of 8 to 10 mL ⅐ kg Ϫ1 actual body weight without positive end-expiratory pressure. No further muscle relaxation was given. The patients were all positioned in the supine or Lloyd-Davies position (Trendelenburg with legs apart) with an arm board for the test arm. All test fluids were administered via a fluid warmer, and a forced-air warming blanket was used to maintain a constant esophageal temperature.
After induction of anesthesia, Masimo Rainbow SET Pulse Co-Oximeter probes (Masimo Corporation, Irvine, CA) were applied to the earlobe and index finger of the patient. A CardioQ EDM probe (Deltex Medical, Chichester, UK) was inserted orally into the esophagus and the position was adjusted to attain the maximal SV.
Steady-State Measurements
In the supine position, after a postinduction period of 5 minutes to allow for hemodynamic stabilization, baseline measures of heart rate, arterial blood pressure, esophageal Doppler-measured SV, PVI, and PI were taken. Based on work by Cannesson et al., 15 a fluid bolus of 500 mL of 130/0.4 tetrastarch colloid solution (Voluven™; Fresenius Kabi, Runcorn, Cheshire, UK) was administered rapidly into a peripheral vein via pressurized IV infusion. A further set of readings was taken 10 minutes after the completion of the infusion. Surgery was then allowed to commence.
Intraoperative Measurements
The esophageal Doppler measured SV continuously throughout surgery and patients were positioned in either the supine or Lloyd-Davies position. If the SV decreased by 10%, a 250-mL bolus of colloid solution was given via fast infusion with a 50-mL syringe, based on a standard SV monitoring algorithm used in esophageal Doppler studies. 4 Readings of heart rate, arterial blood pressure, SV, PVI, and PI were taken before infusion, and 10 minutes after the infusion had finished, as in the steady-state readings. The position was not altered between fluid administration and the test readings; otherwise, the results from that particular bolus were excluded from analysis.
Statistical Analysis
Baseline values for hemodynamic measurements were compared with final values (after the fluid bolus) using paired t test. Patients were classified into responders and nonresponders according to whether or not they had an increase in Doppler-measured SV of 10%. Differences in hemodynamic measurements between responders and nonresponders were compared using the Mann-Whitney U test. P values Ͻ0.05 were considered significant. Receiver operator characteristic (ROC) curves were constructed for the ability of PVI to predict fluid responsiveness. All software analyses were performed using GraphPad Prism 5 for Mac OS X (GraphPad Software, Inc., La Jolla, CA).
RESULTS
Twenty-five patients were recruited into the study ( Table  1 ). The initial steady-state 500-mL bolus was associated with a significant decrease in heart rate, a decrease in systolic blood pressure, an increase in SV, and a decrease in PVI at both finger (P Ͻ 0.001) and earlobe (P Ͻ 0.001) ( Table  2 ). There were 22 responders (88%) to initial fluid bolus and 3 nonresponders. Baseline PVI at both finger (P ϭ 0.012) and earlobe (P ϭ 0.009) was significantly higher in responders compared with nonresponders ( Table 2 ). Figure 1 shows the individual range of responses of PVI to the 500-mL bolus, as measured by the finger probe. ROC analysis demonstrated significant predictive ability of an increase in SV for PVI at both finger and earlobe (Fig. 2) . Area under the curve for finger was 0.96 (95% confidence interval [CI], 0.88 -1.00; P ϭ 0.011) and for earlobe was 0.98 (95% CI, 0.93-1.00; P ϭ 0.008). A baseline finger PVI value of 10 had 86% sensitivity and 100% specificity for predicting a 10% SV increase; at the earlobe, a value of 9.5 had 95% sensitivity and 100% specificity.
Sixty-eight intraoperative fluid boluses of 250 mL were given in response to a decrease in SV of 10%. Of these, 5 sets of readings were excluded because either patient position was changed during the bolus, or the esophageal Doppler probe had to be refocused before the final readings could be taken, leaving 63 sets of readings for analysis. A fluid bolus produced an increase in SV of 10% on 23 occasions (36.5%). Prebolus PVI at the finger probe was significantly higher in responders compared with nonresponders (P ϭ 0.006) ( Table 3 ). PVI at the earlobe had no predictive value during intraoperative conditions. ROC analysis demonstrated significant predictive ability of an increase in SV for PVI at the finger, area under the curve 0.71 (95% CI, 0.57-0.85; P ϭ 0.006), PVI at the ear was not predictive, area under the curve 0.54 (95% CI, 0.39 -0.69; P ϭ 0.594) ( Fig. 3) . A baseline finger PVI value of 10% had 65% sensitivity and 67% specificity for predicting an SV increase.
DISCUSSION
Our results suggest that PVI measured at the finger may be an accurate predictor of fluid responsiveness during preoperative conditions and to a lesser, but still significant, extent in dynamic intraoperative conditions. When PVI is measured at the earlobe, it does not have the same predictive value during surgery. These data support previous work showing that plethysmographic variability can predict fluid responsiveness in cardiac, 15 general surgical, 17 and intensive care patients. 14 Our study contains measures from dynamic intraoperative conditions and preoperative conditions, which may provide a more realistic estimate of the value of PVI for day-to-day use. However, the accuracy of PVI preoperatively is still relevant in clinical practice, because the importance of optimization of the circulating volume early in surgery is increasingly evident, with data showing that patients receiving the majority of their fluid early in the first 40 minutes of surgery experienced a decreased inflammatory response and improved outcome. 4 With regard to intraoperative fluid administration, we found that a finger-measured PVI of Ͼ10% would identify 65% of those patients who would respond to fluid by increasing SV, and a value Ͻ10% would identify 67% of those patients not likely to respond to a fluid bolus. Interestingly, the sensitivity of a 10% decrease in esophageal Doppler-measured SV in identifying fluid responsiveness was 37% in our study. Standard published protocols for guiding fluid therapy using esophageal Dopplermonitored SV recommend giving fluid if the SV decreases by 10% during surgery, which seems a reasonable approach. However, our data indicate that reductions in SV as measured by esophageal Doppler can be related to other factors aside from preload. SV is also dependent on circulatory afterload (systemic vascular resistance), which can alter during major surgery because of the onset of epiduralinduced sympathetic blockade, for example, and from anesthetic drugs themselves, and on contractility, which can also alter with changes in circulating catecholamine levels. These factors may also explain the change in predictive ability of intraoperative PVI relative to steady-state PVI as well as changes in muscle relaxation leading to irregularities in tidal volume, or the effect of leaving the oximeter probe on the same finger for a long duration: all anesthesiologists have experienced moving the probe to a different finger and finding changes in oxygen saturation. Furthermore, changes in patient positioning from the supine to Lloyd-Davies position between sets of readings may alter cardiac preload and hence affect fluid responsiveness. Conventional "static" hemodynamic variables such as heart rate, arterial blood pressure, central venous pressure, and urine output are not thought to be reliable predictors of fluid responsiveness. 18 Dynamic indices, as opposed to static, seem to more reliably predict preload responsiveness 9 -11,19 and perhaps reduce hospital stay when used as part of a goal-directed algorithm. 20 In 2 small trials, PVI was found to match SVV in indicating hypovolemia 21 and fluid responsiveness. 22 A significant measured SV increase may also be predicted by pulse pressure variation and SVV, both dynamic assessors of preload responsiveness similar to PVI, but requiring arterial cannulation. 23 One advantage of PVI is that it is very simple to use and is completely noninvasive, but similar to other dynamic assessors of preload responsiveness, it requires the patient's lungs to be mechanically ventilated and the patient to be in stable heart rhythm. Previous work involving the PVI algorithm has focused on patients undergoing cardiac 13, 15 or major abdominal surgery 22 and routine monitoring in these patients involved arterial and central venous cannulation; the benefit of using PVI in these circumstances is limited. For these reasons, we decided to focus on the low-risk group, for whom a noninvasive, dynamic assessor of fluid responsiveness would be most useful. Currently, only the esophageal Doppler is a comparable monitor in terms of invasiveness and so we chose to assess the value of PVI in relation to the esophageal Doppler, because the esophageal Doppler has a small, but significant evidence base in major abdominal surgery. 4 -7,24 Despite these benefits, there are potential drawbacks to esophageal Doppler use. Signal optimization can be difficult and it has been suggested that training is required to optimize the reproducibility of data. 25 Furthermore, pooled analysis of 57 measurements from 2 studies has suggested that cardiac output measured by esophageal Doppler may deviate by 42% from the true value, although this is broadly comparable with other indirect determinants of cardiac output. 26 The esophageal Doppler signal is interrupted by the use of surgical diathermy, changes in patient positioning, and placement of orogastric or nasogastric tubes and there is also the small but not inconsequential cost of the disposable Doppler probes. In contrast, the PVI signal is not influenced by surgical diathermy but it can be limited by inadequate tissue perfusion in high-risk patients. 17 This did not influence the results in our study group.
The limitations of this study relate to the incidence of responders and nonresponders in both steady-state and intraoperative measurements and the volumes of fluid used. In the steady-state readings, there were only 3 patients classified as nonresponders, but despite this, a cutoff PVI value of 10% was 100% specific at identifying those patients. A relatively large baseline fluid bolus of 500 mL was used in an attempt to clearly delineate responders from nonresponders. Interestingly, in our study group, this was associated with a decrease in arterial blood pressure, which is likely to be unrelated, and probably attributable to decreasing systemic vascular resistance from the effects of anesthetic drugs, or even the epidural test dose of bupivacaine. An SV increase of Ͼ10% was deemed significant for both arms of our study in line with other published work using fluid boluses of different volumes. 23 If PVI is going to be a viable alternative to esophageal Doppler, it needs to at least match its performance. We are aware of no direct patient outcome studies comparing PVI-driven protocols with esophageal Doppler protocols; however, recent work comparing a PVI protocol with conventional fluid therapy has shown that despite less crystalloid being used in the PVI group, lactate levels were lower in the PVI group, although clinical outcome variables were unchanged. 27 Finally, it has been suggested that the plethysmographic waveform is strongest at the ear, 28 although the reliability of each PVI site has yet to be determined. We compared PVI as measured at 2 sites, finger and earlobe, and found that, although the PI was very low at the earlobe compared with the finger, the value of PVI at the earlobe still retained the ability to predict preload responsiveness in steady-state conditions. Manufacturer data suggest that the PI needs to be Ͼ1.0 for PVI to be reliable and it may be that by using a smaller 250-mL fluid bolus intraoperatively, ear PVI lost its predictive ability because of the low PI.
In conclusion, this study shows that PVI has some value in predicting fluid responsiveness in low-risk patients undergoing colorectal surgery, particularly at the beginning of the procedure. Further research in larger populations is needed to establish cutoff values for PVI in dynamic conditions, and research is also indicated to learn whether a PVI-driven fluid protocol can have the same clinical benefit as an esophageal Doppler SV protocol. If further studies confirm the initial promise of PVI, the benefits of optimizing circulating volume may be extendable to a wider patient population because of its low cost and noninvasiveness.
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